Catalyst Wire Dossier Catalyst Wire Dossier

Limtop

Imiquimod · Moberg Pharma AB
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Limtop, covering 2012-05-28 to 2013-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head [Phase 2]

See pricing